CTOs on the Move

Babson Diagnostics

www.babsondx.com

 
Babson Diagnostics is bringing medically-accurate blood testing to the pharmacy, and empowering people to take charge of their health by reimagining the entire blood testing process from ordering, collection, handling, analyzing, and reporting of results, making it less invasive and more convenient, accessible, and patient-centered.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.babsondx.com
  • 1205 Sheldon Cove Suite 2-J
    Austin, TX USA 78753
  • Phone: 512.562.2473

Executives

Name Title Contact Details

Funding

Babson Diagnostics raised $13.7M on 09/24/2020
Babson Diagnostics raised $31M on 06/29/2021

Similar Companies

Sullivan Arc Inc

Sullivan Arc Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Monticello, NY. To find more information about Sullivan Arc Inc, please visit www.sullivanarc.org

BioStorage Technologies Inc

BioStorage Technologies Inc is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Beekeeper's Naturals

Fill your medicine cabinet with clean & natural remedies (that actually work). Immune support to energy support. Experience hive-powered health. Shop Now

ContraVir Pharmaceuticals, Inc

ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.

High Point Regional Health System

As a not-for-profit Health System governed by a volunteer, community-based board of trustees, High Point Regional offers a wide variety of inpatient and outpatient care.